Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients

Presently, there is inconclusive evidence regarding the most effective treatment for idiopathic nonhistaminergic acquired angioedema (InH-AAE). Omalizumab may, however, prove to be a promising option. This case report describes two patients who presented with recurrent angioedema attacks, which was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Reports Immunol
Main Authors: Brunetta, Enrico, Shiffer, Dana, Folci, Marco, Achenza, Maria I. S., Puggioni, Francesca, Heffler, Enrico, Furlan, Raffaello, Canonica, Giorgio W.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2018
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6081528/
https://ncbi.nlm.nih.gov/pubmed/30140474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8067610
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados